Niagen Bioscience (NAGE) Return on Capital Employed Growth (5y) (2016 - 2025)
Niagen Bioscience (NAGE) Return on Capital Employed Growth (5y) (2016 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Niagen Bioscience | 253.47 Mn | 186.92 Mn | 19.98 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 13,728.00 |
| Mar 31, 2025 | 14,734.00 |
| Dec 31, 2024 | 13,492.00 |
| Sep 30, 2024 | 9,468.00 |
| Jun 30, 2024 | 16,390.00 |
| Mar 31, 2024 | 11,249.00 |
| Dec 31, 2023 | 9,323.00 |
| Sep 30, 2023 | 7,172.00 |
| Jun 30, 2023 | 3,896.00 |
| Mar 31, 2023 | 976.00 |
| Dec 31, 2022 | -2,115.00 |
| Sep 30, 2022 | -4,409.00 |
| Jun 30, 2022 | -5,196.00 |
| Mar 31, 2022 | -2,602.00 |
| Dec 31, 2021 | -3,722.00 |
| Mar 31, 2018 | 9,605.00 |
| Dec 30, 2017 | 29,295.00 |
| Sep 30, 2017 | 2,930.00 |
| Dec 31, 2016 | -6,249.00 |